The data shown below were collected from the profiles of 35 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Chemotherapy in Combination With Immune Checkpoint Inhibitors for the First-Line Treatment of Patients With Advanced Non-small Cell Lung Cancer: A Systematic Review and Literature-Based Meta-Analysis
|
|---|---|
| Published in |
Frontiers in oncology, April 2019
|
| DOI | 10.3389/fonc.2019.00264 |
| Pubmed ID | |
| Authors |
Alfredo Addeo, Giuseppe Luigi Banna, Giulio Metro, Massimo Di Maio |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Switzerland | 3 | 9% |
| India | 1 | 3% |
| Hungary | 1 | 3% |
| Ireland | 1 | 3% |
| Hong Kong | 1 | 3% |
| Venezuela, Bolivarian Republic of | 1 | 3% |
| United Kingdom | 1 | 3% |
| Spain | 1 | 3% |
| Unknown | 25 | 71% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 19 | 54% |
| Scientists | 12 | 34% |
| Practitioners (doctors, other healthcare professionals) | 3 | 9% |
| Unknown | 1 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 76 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 76 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Postgraduate | 12 | 16% |
| Student > Master | 9 | 12% |
| Student > Bachelor | 9 | 12% |
| Other | 7 | 9% |
| Student > Ph. D. Student | 7 | 9% |
| Other | 13 | 17% |
| Unknown | 19 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 26 | 34% |
| Immunology and Microbiology | 7 | 9% |
| Biochemistry, Genetics and Molecular Biology | 5 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 7% |
| Nursing and Health Professions | 2 | 3% |
| Other | 8 | 11% |
| Unknown | 23 | 30% |
Attention Score in Context
This research output has an Altmetric Attention Score of 30. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 May 2023.
All research outputs
#1,357,560
of 26,177,525 outputs
Outputs from Frontiers in oncology
#237
of 22,921 outputs
Outputs of similar age
#28,840
of 350,791 outputs
Outputs of similar age from Frontiers in oncology
#7
of 292 outputs
Altmetric has tracked 26,177,525 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,921 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 350,791 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 292 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.